Getinge Group Q4 Report 2007
Reporting period January – December
• Orders received increased by 24.1% to SEK 16,519 million (13,316)
• Net sales increased by 26.5% to SEK 16,445 million (13,001)
• Profit before tax amounted to SEK 1,775 million (1,728)
• Net profit amounted to SEK 1,261 million (1,259)
• Earnings per share amounted to SEK 6.24 (6.21)
• Dividend per share proposed at SEK 2.40 (2.20)
• Acquisition of Boston Scientific’s cardio and vascular surgery divisions
• The Board of Getinge AB proposes a new share issue of approximately SEK 1,500 million for financing and continued expansion.
• New financial targets
Fourth quarter
• Orders received increased organically by 5.5%
• Net sales increased by 29.1% to SEK 5,157 million (3,995)
• Operating profit (EBITA) before restructuring increased by 29.2 % to SEK 1,096 million (848)